
Immunotherapy for the Treatment of Non-Small Cell Lung Cancer
Diagnosis for NSCLC
Diagnosis for NSCLC
- Prior to initiation of immunotherapy, tests recommended by the majority of the Task Force included computerized tomography (CT) of the chest, abdomen, and pelvis and thyroid function tests (in addition to routine lab tests).
Table 1. PD-L1 Assay Characteristics and Performance in NSCLC
...1. PD-L1 Assay Characteristics and P...
Treatment for NSCLC
...Treatment for NSCL...
Figure 1. Advanced/Metastatic NSCLC Treatment Algorithm
...Advanced/Metastatic NSCLC Treatment Alg...
...for all newly diagnosed patients is rec...
...ne pembrolizumab monotherapy should be used for pa...
...ts with squamous histology and PD-L1 T...
...th non-squamous, advanced NSCLC and...
...tezolizumab, nivolumab, or pembrolizumab (...
...nts with non-squamous, advanced NSCLC with PD-L1 T...
...mbrolizumab is recommended first-line in...
...b should be used in stage III patients who...
Monitoring for NSCLC
...Monitoring f...
...uring and Monitoring Radiographic ResponseObtai...
...zing, Monitoring and Managing Treat...
...e 2. FDA-approved Programmed Cell...